Media Watch
Tag:
ANALYSIS: Deal, or no deal?
This weekend saw the South African government and Swiss pharmaceutical giant Lonza in an on-again, off-again and then on-again agreement on the establishment of a South African-based drug plant that could lower the cost of ARVs.
On Friday (10 February 2012) it seemed that last year’s speculation around the establishment of a state-owned drug manufacturing company was set to become a reality after the Department of Science and Technology announced that plans to develop the manufacturing facility would go ahead.
However, the next day, The Saturday Star reported that the government’s announcement was premature after the foreign pharmaceutical company released a statement indicating that the process was still at a very early stage.
State drug company: Seeking other solutions
The debate over whether the establishment of a drug manufacturing company owned by the government would be beneficial rages on.Mixed feelings over proposed state-owned drug company
According to newspaper reports, the jury is out over the potential benefits and losses of a home-grown, state-owned pharmaceutical company.Page 1 of 1 pages
